Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

Sung W. Choi, Carrie L. Kitko, Thomas Braun, Sophie Paczesny, Gregory Yanik, Shin Mineishi, Oleg Krijanovski, Dawn Jones, Joel Whitfield, Kenneth Cooke, Raymond J. Hutchinson, James L. M. Ferrara, John E. Levine

Blood (2008) 112 (4): 1539–1542.

https://doi.org/10.1182/blood-2008-02-138867

Published: 2008

Journal Articles

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

John E. Levine, Sophie Paczesny, Shin Mineishi, Thomas Braun, Sung W. Choi, Raymond J. Hutchinson, Dawn Jones, Yasser Khaled, Carrie L. Kitko, Daniel Bickley, Oleg Krijanovski, Pavan Reddy, Gregory Yanik, James L. M. Ferrara

Blood (2008) 111 (4): 2470–2475.

https://doi.org/10.1182/blood-2007-09-112987

Published: 2008

Includes: Supplemental data

Journal Articles

Etanercept Plus Methylprednisolone as Initial Therapy for Acute GVHD.

John E. Levine, MD, MS, Sophie Paczesny, MD, Shin Mineishi, MD, Thomas Braun, PhD, Sung W. Choi, MD, Raymond J. Hutchinson, MD, MS, Dawn Jones, RN, Yasser Khaled, MD, Carrie Kitko, MD, Oleg Krijanovski, MD, Pavan Reddy, MD, Gregory Yanik, MD, James L.M. Ferrara, MD

Blood (2007) 110 (11): 39.

https://doi.org/10.1182/blood.V110.11.39.39

Published: 2007

Journal Articles

Superior Long Term Progression Free Survival of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Compared to Autologous Hematopoietic Stem Cell Transplantation after Identical Conditioning Regimen.

Yasser Khaled, MD, Koji Kato, MD, John E. Levine, MD, Smitha Mellacheruvu, MD, Andrzej Jakubowiak, MD, Oleg Krijanovski, MD, Edward Peres, MD, Pavan Reddy, MD, Kevin Knott, Greg Yanik, MD, James Ferrara, MD, Shin Mineishi, MD

Blood (2007) 110 (11): 3031.

https://doi.org/10.1182/blood.V110.11.3031.3031

Published: 2007

Journal Articles

Changes in TNFR1 Levels in the First Week Post-Myeloablative HSCT Correlate with Severity and Incidence of GVHD and 1y TRM.

John E. Levine, MD, MS, Carrie Kitko, MD, Gregory Yanik, MD, Thomas Braun, PhD, Sophie Paczesny, MD, Shin Mineishi, MD, Oleg Krijanovski, MD, Dawn Jones, RN, Kenneth R. Cooke, MD, Joel Whitfield, Raymond J. Hutchinson, MD, MS, James L.M. Ferrara, MD

Blood (2006) 108 (11): 37.

https://doi.org/10.1182/blood.V108.11.37.37

Published: 2006

Journal Articles

Histone Deacetylase Inhibitors Induce Immuno-Dominant Suppression of Dendritic Cells.

Pavan Reddy, MD, Yoshinobu Maeda, MD, PhD, Raimon Duran-Struuck, DVM, Oleg Krijanovski, MD, PhD, Charles Dinarello, MD, James L. Ferrara, MD

Blood (2005) 106 (11): 456.

https://doi.org/10.1182/blood.V106.11.456.456

Published: 2005

NARROW

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

Etanercept Plus Methylprednisolone as Initial Therapy for Acute GVHD.

Superior Long Term Progression Free Survival of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Compared to Autologous Hematopoietic Stem Cell Transplantation after Identical Conditioning Regimen.

Changes in TNFR1 Levels in the First Week Post-Myeloablative HSCT Correlate with Severity and Incidence of GVHD and 1y TRM.

Histone Deacetylase Inhibitors Induce Immuno-Dominant Suppression of Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

Etanercept Plus Methylprednisolone as Initial Therapy for Acute GVHD.

Superior Long Term Progression Free Survival of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Compared to Autologous Hematopoietic Stem Cell Transplantation after Identical Conditioning Regimen.

Changes in TNFR1 Levels in the First Week Post-Myeloablative HSCT Correlate with Severity and Incidence of GVHD and 1y TRM.

Histone Deacetylase Inhibitors Induce Immuno-Dominant Suppression of Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only